During the past decade, Kaposi Mor Oktato Korhaz, Belgyogyaszati Osztaly conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaposi Mor Oktato Korhaz, Belgyogyaszati Osztaly" #1 collaborator was "UCB Pharma" with 1 trials as a collaborator and "Wyeth is now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Kaposi Mor Oktato Korhaz, Belgyogyaszati Osztaly" are "Chronic Myeloid Leukemia" (2 trials), "Acute Myeloid Leukemia" (1 trials), "Crohn's Disease" (1 trials) and "Lymphoma" (1 trials). Many other conditions were trialed in "Kaposi Mor Oktato Korhaz, Belgyogyaszati Osztaly" in a lesser frequency.

Most popular intervention types in "Kaposi Mor Oktato Korhaz, Belgyogyaszati Osztaly" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Bosutinib" (1 trials), "CP-690,550" (1 trials), "Inotuzumab Ozogamicin (CMC-544)" (1 trials), "Placebo" (1 trials) and "bosutinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kaposi Mor Oktato Korhaz, Belgyogyaszati Osztaly" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Kaposi Mor Oktato Korhaz, Belgyogyaszati Osztaly". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Kaposi Mor Oktato Korhaz, Belgyogyaszati Osztaly, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kaposi Mor Oktato Korhaz, Belgyogyaszati Osztaly, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".